Ceapro Inc. (CRPOF)

0,1700 0,0000 (0,00%) Börsenschluss: 11:58AM EDT

Ceapro Inc.

7824 – 51 Avenue NW
Edmonton, AB T6E 6W2
Canada
780-421-4555
https://www.ceapro.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.	CEO, President & Director	409,67k	N/A	1954
Ms. Stacy Prefontaine C.A., CPA, CA, CPA	CFO & Corporate Secretary	170,44k	N/A	N/A
Dr. Bernhard Seifried	Senior Director of Research & Technology	N/A	N/A	N/A
Mr. Michel Regnier P. Eng.	Senior Vice President of Technical Operations	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Ceapro Inc., a biotechnology company, engages in the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using proprietary technology, natural, and renewable resources in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of the technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also develops and commercializes active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. The company was incorporated in 1997 and is headquartered in Edmonton, Canada. As of June 3, 2024, Ceapro Inc. operates as a subsidiary of Aeterna Zentaris Inc.

Corporate Governance

Ceapro Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.